When you learn you have bladder cancer, it’s only natural to ask: "Can I survive this, for how long, and can I expect to be cured?" You may have searched online for survival rate information. These ...

A large meta-analysis suggests radical cystectomy offers better survival outcomes compared with trimodality therapy for patients with muscle-invasive bladder cancer. Radical cystectomy (RC) for muscle ...

TAR-200 demonstrated a high disease-free survival and bladder preservation rates in BCG-unresponsive, high-risk non-muscle-invasive bladder cancer. TAR-200, an intravesical chemotherapy releasing ...

Non-muscle invasive bladder cancer is cancer that’s only in the inner lining of your bladder. It hasn’t grown into the muscle wall. Your doctor may also call it superficial bladder cancer, urothelial ...

Aug 12 (Reuters) - Pfizer (PFE.N), opens new tab said on Tuesday its cancer drug Padcev, in combination with Merck's (MRK.N), opens new tab Keytruda, significantly improved survival rates in patients ...

N1 Single lymph node metastasis, 2 cm or less in greatest dimension N1 Single regional lymph node metastasis in the true pelvis (hypogastric, obturator, external iliac or presacral lymph node) N2 ...

Adjuvant nivolumab (Opdivo) continued to show benefits in disease-free survival (DFS) compared with placebo in patients with muscle-invasive urothelial carcinoma (MIUC) who underwent radical surgery, ...

The perioperative enfortumab vedotin plus pembrolizumab (EV-P) substantially increased the frequency of adverse events (AEs), ...

Neoadjuvant mitomycin C showed a favorable safety profile with mild to moderate side effects, including hematuria, dysuria, and itchy scalp. The trial did not show significant improvement in 12-month ...